A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-beta) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles.
about
The sub-optimal response to controlled ovarian stimulation: manageable or inevitable?Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approachTesting for Ovarian Reserve in Assisted Reproduction programs: the current point of view.A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment.Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count.Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve.Approaches to improve the diagnosis and management of infertilityIndividualized follicle-stimulating hormone dosing and in vitro fertilization outcome in agonist downregulated cycles: a systematic review.Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome.Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles.
P2860
Q26800627-6D187CC2-F228-488D-9636-D3CABB72ED09Q28280088-D83E0BF5-ECB4-430C-833E-5A9808D1B6D9Q34608174-7914D03D-969E-47B8-A511-48FC0ADED256Q36270562-4C3D9EB3-A754-427D-8B6A-422247B3215FQ36599421-42083E36-7A5F-4DF8-B713-2019E9070C0BQ36995774-F2B8BB59-6948-485A-BFA5-FAA33B3C2208Q37214916-98B7148B-D2B6-4FBA-BB4E-6EC5DED21D44Q38968422-1A66454F-4417-44DA-9145-1E78A0869944Q44013164-C0763E02-F54F-4663-A76B-0B3E2887ACF5Q47221797-49EF026A-8B9A-4C12-A54E-1094E74C1734Q48605923-003D70F0-10F9-49F4-B550-7C8EE253809BQ50927458-59FCB6E8-2C43-43E3-BAB3-F9C5714DB3BB
P2860
A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-beta) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A prospective randomized clini ...... rm injection treatment cycles.
@ast
A prospective randomized clini ...... rm injection treatment cycles.
@en
type
label
A prospective randomized clini ...... rm injection treatment cycles.
@ast
A prospective randomized clini ...... rm injection treatment cycles.
@en
prefLabel
A prospective randomized clini ...... rm injection treatment cycles.
@ast
A prospective randomized clini ...... rm injection treatment cycles.
@en
P2093
P1476
A prospective randomized clini ...... rm injection treatment cycles.
@en
P2093
P356
10.1016/S0015-0282(00)01643-5
P407
P577
2001-01-01T00:00:00Z